Showing results (1791-1800 of 2,171) with videos related to

Sort By:
Pageof 218
Clinical Chemistry|October 11, 2005
Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease studyNicolas von Ahsen, Victor W Armstrong, Christoph Behrens, et al.
American Heart Journal|September 29, 2014
Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary interventionAkshay Bagai, Phillip J Schulte, Christopher B Granger, et al.
Acta Anaesthesiologica Scandinavica|June 16, 2004
Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypassJ P Braun, T Schroeder, S Buehner, et al.
The American Journal of Cardiology|July 28, 2004
Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3)Jeptha P Curtis, John H Alexander, Yao Huang, et al.
American Heart Journal|December 13, 2005
Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trialsCamille G Frazier, Svati H Shah, Paul W Armstrong, et al.
Journal of the American Academy of Dermatology|June 9, 2015
Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burdenErika L Hagstrom, Shivani Patel, Chante Karimkhani, et al.
Circulation|July 9, 2003
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarctionL Wallentin, P Goldstein, P W Armstrong, et al.
International Journal of Cardiology|May 13, 2017
Hospital variation in treatment and outcomes in acute coronary syndromes: Insights from the Alberta Contemporary Acute Coronary Syndrome Patients Invasive Treatment Strategies (COAPT) studyKevin R Bainey, Padma Kaul, Paul W Armstrong, et al.
BMC Genomics|June 27, 2007
Development of the first marmoset-specific DNA microarray (EUMAMA): a new genetic tool for large-scale expression profiling in a non-human primateNicole A Datson, Maarten C Morsink, Srebrena Atanasova, et al.
European Heart Journal. Acute Cardiovascular Care|August 1, 2015
Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS TrialChiara Melloni, Jan H Cornel, Gail Hafley, et al.
Pageof 218